Last updated: 2026-02-08 04:46:33 ET
The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.
The U.S. Postal Service saw quarterly adjusted operating income tumble by nearly two-thirds as parcel volume fell by double digits and revenue contrac...
CEO Andy Jassy struck a defiant tone in the company's conference call to discuss results, swiping at competitors and boasting about AWS's many new off...
Strategy executives Phong Le and Andrew Kang say the company is on a strong financial footing despite it now being down 17.5% on its Bitcoin holdings.
Silver’s decline far outpaced that of gold on Thursday, with its sharp price losses leading to a turn lower for the week, even as gold looked to rec...
Workday cuts 400 jobs as software stocks tumble
Just as Novo Nordisk showed signs of a recovery, another cold shower hit investors as the drugmaker surprise prereleased its 2026 forecast late Tuesday, sending shares tumbling.
The maker of Ozempic and Wegovy blamed pricing pressures and competition for its downbeat outlook.
The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key U.S. market.
Bitcoin hit its lowest level since the “liberation day” selloff last April.
